Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10653731 Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency

Overview Structured Data Issues Contributors Activity

Is a

Current Assignee

Vigene Biosciences

Date Filed

July 15, 2019

Date of Patent

May 19, 2020

Patent Applicant

Vigene Biosciences

Patent Application Number

16512051

Patent Citations

US Patent 10202657 Adeno-associated virus virions with variant capsid and methods of use thereof

US Patent 10214566 Mutant adeno-associated virus virions and methods of use thereof

US Patent 10214730 Adeno-associated-virus Rep sequences, vectors and viruses

US Patent 10214785 Adeno-associated virus virions with variant capsid and methods of use thereof

US Patent 10227611 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

US Patent 10265417 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

US Patent 10266846 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

US Patent 10301650 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

US Patent 10294452 Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells

US Patent 10000772 Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

•••

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 10653731 Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool